FierceBiotech ٢٨ يناير ٢٠٢٦ FDA puts clinical hold on Regenxbio gene therapies weeks before approval ruling
FierceBiotech ٢٨ يناير ٢٠٢٦ 'We have an expansive view:' Kardigan CEO knits sharper trials, digital health into cardio strategy
FierceBiotech ٢٨ يناير ٢٠٢٦ With 200 JPM meetings, Novo Nordisk BD head searches for the next Metsera
FierceBiotech ٢٧ يناير ٢٠٢٦ Rethinking heart attacks as nervous system gone haywire sparks potential new drug targets
FierceBiotech ٢٧ يناير ٢٠٢٦ TD Cowen picks top 3 medtech prospects across its ‘Bones, Bots, and No More Shots’ portfolio
FierceBiotech ٢٧ يناير ٢٠٢٦ 'AI-native' outpatient surgery startup Oath Surgical inks Nvidia partnership
FierceBiotech ٢٧ يناير ٢٠٢٦ United Therapeutics' bioengineered temporary liver shows promise in phase 1 trial
FierceBiotech ٢٧ يناير ٢٠٢٦ From gene therapies to … firearms? Italian biotech makes unexpected strategic pivot
FierceBiotech ٢٧ يناير ٢٠٢٦ Lisata reclaims China rights to solid tumor candidate ahead of acquisition
FierceBiotech ٢٧ يناير ٢٠٢٦ After patient death, FDA lifts hold on 1 of 2 late-stage trials testing Intellia’s CRISPR therapy
FierceBiotech ٢٧ يناير ٢٠٢٦ Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
FierceBiotech ٢٦ يناير ٢٠٢٦ Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial
FierceBiotech ٢٦ يناير ٢٠٢٦ European investment firm Gimv calls it quits on new life science financing
FierceBiotech ٢٦ يناير ٢٠٢٦ Guardant Health gets FDA nod to expand use of blood test for colon cancer